Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

96
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
96
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

109
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
109

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cutaneous Sensory Stimulation Intensity Modulates Beta-Band Event-Related Desynchronization and Synchronization Amplitudes.

The European journal of neuroscience·2026
Same author

Dehydro-metabolites of siphonaxanthin predominate in skin tissues and retain biological activity in keratinocytes.

Bioscience, biotechnology, and biochemistry·2026
Same author

Beta event-related synchronization after muscle contraction is modulated by voluntary movement patterns: An EEG and MEG study.

NeuroImage·2026
Same author

Targeting the METTL1/m7G axis as a therapeutic strategy in myeloid leukemia.

Blood·2026
Same author

Combining menin and MEK inhibition to target poor prognosis KMT2A-rearranged RAS pathway-mutant acute myeloid leukemia.

Blood advances·2026
Same author

MECOM promotes leukemia progression and inhibits mast cell differentiation through functional competition with GATA2.

Leukemia·2026

Related Experiment Video

Updated: Mar 28, 2026

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

25.8K

Development of hematopoietic stem cell-targeted lipid nanoparticles through lipid composition optimization.

Takamasa Hiraki1, Keita Yamamoto2, Yu-Hsuan Chang2

  • 1Department of Pediatrics, The University of Tokyo, Tokyo, Japan.

Experimental Hematology
|March 26, 2026
PubMed
Summary

Researchers optimized lipid nanoparticles (LNPs) for gene editing in hematopoietic stem cells (HSCs). This machine learning-guided approach improved delivery efficiency and viability, showing promise for treating blood disorders.

More Related Videos

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

8.1K
Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins
11:30

Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins

Published on: August 31, 2019

25.6K

Related Experiment Videos

Last Updated: Mar 28, 2026

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

25.8K
Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

8.1K
Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins
11:30

Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins

Published on: August 31, 2019

25.6K

Area of Science:

  • Biomedical Engineering
  • Molecular Biology
  • Hematology

Background:

  • Hematopoietic stem cell (HSC)-targeted gene editing offers potential for hereditary blood disorders.
  • Efficient and safe delivery of gene editing tools into HSCs remains a significant challenge.
  • Lipid nanoparticles (LNPs) are promising for nucleic acid delivery but face transfection efficiency hurdles in HSCs.

Purpose of the Study:

  • To develop and optimize HSC-targeted LNPs for enhanced gene editing delivery.
  • To improve transfection efficiency and cell viability in HSCs using machine learning-guided LNP design.

Main Methods:

  • Integrated Bayesian optimization with functional amino lipids to design HSC-targeted LNPs.
  • Evaluated LNP transfection efficiency and cell viability in HSCs.
  • Performed ex vivo TP53 gene editing in cord blood (CB) CD34+ cells.
  • Assessed RNA delivery into primary human monocytic leukemia cells.

Main Results:

  • Optimized LNPs demonstrated significantly improved transfection efficiency and preserved cell viability compared to previous formulations.
  • Achieved up to 40% on-target TP53 gene editing efficiency in ex vivo CB CD34+ cells.
  • One LNP formulation showed efficient RNA delivery in human monocytic leukemia cells.

Conclusions:

  • Machine learning-guided LNP design is a powerful strategy for advancing HSC-targeted therapies.
  • LNP-based gene editing platforms show significant promise for treating hereditary and malignant hematopoietic disorders.
  • Optimized LNPs represent a viable tool for efficient gene editing in HSCs.